Contrast Media/Contrast Agents Market

Contrast Media/Contrast Agents Market Size, Share & Trends Analysis Report by Type (Iodinated Contrast Media, Gadolinium-based Contrast Media, Microbubble Contrast Media, Barium-based Contrast Media), by Modality (X-ray/CT, MRI, Ultrasound), by Administration (Intravascular Route, Oral Route, Rectal Route, Others), by Indication (Cardiovascular Disorders, Cancer, Gastrointestinal Disorders, Musculoskeletal Disorders), by Application (Radiology, Interventional Radiology, Interventional Cardiology), by End User (Hospital, Clinics, & Ambulatory Surgery Centers, Diagnostic Imaging Centers), by Region (North America, Europe, Asia Pacific, Latin America and Middle East & Africa) - Global Industry Assessment (2016 - 2021) & Forecast (2022 - 2028)

Frequently Asked Questions

  • What is the global demand for Contrast Media/Contrast Agents in terms of revenue?

    The global Contrast Media/Contrast Agents valued at USD 4,729.20 Million in 2020 and is expected to reach USD 5,813.30 Million in 2028 growing at a CAGR of 3.5%

  • Which are the prominent players in the market?

    The prominent players in the market are GE Healthcare (US), Bracco Imaging SPA (Italy), Bayer AG (Germany), Guerbet (France), Lantheus Medical Imaging Inc. (US), Unijules Life Sciences (India), J.B. Chemicals and Pharmaceuticals Ltd. (India), SANOCHEMIA Pharmazeutika GmbH (Austria), Taejoon Pharm (South Korea), Jodas Expoim (India), Nano Therapeutics Pvt. Ltd. (India), Kiran X-ray (India), iMax Diagnostic Imaging Limited (Ireland), YZJ Group (China), Livealth Biopharma Pvt. Ltd. (India), Trivitron Healthcare Pvt. Ltd. (India), Novalek Pharmaceuticals Pvt. Ltd. (India), Unispire Biopharma Private Limited (India), Acro Lifesciences (I) Pvt. Ltd. (India), Congruent Pharmachem Private Limited (India), Stanex Drugs & Chemical Pvt. Ltd. (India), Beijing Beilu Pharmaceutical Co., Ltd. (China), Rege Imaging & Cine Films Private Limited (India), K DIAM EXIM (India), Onko Ýlaç San. ve Tic. A.Þ. (Turkey), and Subhra Pharma Pvt. Ltd. (India).

  • At what CAGR is the market projected to grow within the forecast period?

    The market is project to grow at a CAGR of 3.5% between 2021 and 2028.

  • What are the driving factors fueling the growth of the market.

    The driving factors of the Contrast Media/Contrast Agents include

    • Rising prevalence of chronic diseases

  • Which region accounted for the largest share in the market?

    North America was the leading regional segment of the Contrast Media/Contrast Agents in 2020.

Request Sample Buy Now